Dr Jen Owens, founder of Ireland’s award-winning Glow Clinic, told me earlier this year: "Much like clothing, your aesthetic ...

BioMarin Pharmaceutical’s strong rare disease drug portfolio and Amicus acquisition drive a ‘Buy’ rating. Click here to read my latest analysis of BMRN stock.

Gossamer Bio advances the Feb. 2026 PROSERA Phase 3 readout for seralutinib in PAH, with expanded endpoints and a new ILD trial. Learn why GOSS stock is a hold.

Discover how bioeconomics integrates economics and biology to explain resource management and economic events. Learn about ...

Biotech’s slump may finally be over in 2026. In interviews with BioSpace, Zymeworks’ CEO Ken Galbraith and Zai Lab’s ...

Representatives of companies including AbbVie, Eli Lilly, Johnson & Johnson and Merck have voiced concerns about the FDA’s ...

This year, sustainable finance greenwashing came into fashion with questionable green loans, while ‘greenrinsing’ – shifting climate targets after luring investment – cast a shadow over ...

Pierre Aury gives readers a renewable fuels guide. As the International Maritime Organization has decided to postpone by one year the approval of its proposed Net Zero Framework (NZF) we have decided ...

In The Matrix, human beings are a literal (and metaphorical) power source – specifically, they supply bio-electricity to our AI overlords. Fortunately, enslavement to robotic masters in a ...

As United States agriculture navigates the complexities of global markets, evolving energy demands, and sustainability goals, the role of biofuels, particularly ethanol and renewable diesel, remains ...

Oil majors, including Shell, BP, and TotalEnergies, are scaling back or delaying biofuel projects despite earlier commitments to ramp up production. Shell’s decision to cancel its massive Rotterdam ...

It’s obvious, isn’t it. Plants turn sunlight into food – stored energy – so if we turn that food into fuels, we should get sustainable biofuels with zero carbon emissions, right? Wrong, utterly wrong.